Nutritional Indexes as Predictors of Survival and Their Genomic Implications in Gastric Cancer Patients

References

• Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713. doi:10.1158/1055-9965.EPI-13-1057
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38. doi:10.5114/pg.2018.80001
   PubMed Web of Science ®Google Scholar
• International WCRF. Diet, nutrition, physical activity and stomach cancer 2016. Available from: https://www.wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf.
   Google Scholar
• Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N. Molecular pathology of gastric cancer: research and practice. Pathol Res Pract. 2011;207(10):608–612. doi:10.1016/j.prp.2011.09.006
   PubMed Web of Science ®Google Scholar
• Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, Rubio CA, Mini E, Nesi G. Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol. 2011;17(3):290–299. doi:10.3748/wjg.v17.i3.290
   PubMed Web of Science ®Google Scholar
• Sun M, Nie FQ, Wang ZX, De W. Involvement of lncRNA dysregulation in gastric cancer. Histol Histopathol. 2016;31(1):33–39. doi:10.14670/HH-11-655
   PubMed Web of Science ®Google Scholar
• Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556–565. doi:10.1634/theoncologist.2009-0285
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhao M, Li J, Lou G, Yuan Y, Bu S, Xi Y. Obesity-associated digestive cancers: a review of mechanisms and interventions. Tumour Biol. 2017;39(3):1010428317695020doi:10.1177/1010428317695020
   Google Scholar
• Network C. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–209.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, Gong G, Li G. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22(8):1395–1408. doi:10.1158/1055-9965.EPI-13-0042
   PubMed Web of Science ®Google Scholar
• Lee JH, Park B, Joo J, Kook M-C, Kim Y-I, Lee JY, Kim CG, Choi IJ, Eom BW, Yoon HM, et al. Body mass index and mortality in patients with gastric cancer: a large cohort study. Gastric Cancer. 2018;21(6):913–924. doi:10.1007/s10120-018-0818-x
   PubMed Web of Science ®Google Scholar
• Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol. 2014;20(16):4586–4596. doi:10.3748/wjg.v20.i16.4586
   PubMed Web of Science ®Google Scholar
• Trestini I, Carbognin L, Bonaiuto C, Tortora G, Bria E. The obesity paradox in cancer: clinical insights and perspectives. Eat Weight Disord. 2018;23(2):185–193. doi:10.1007/s40519-018-0489-y
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–1005.
   PubMedGoogle Scholar
• Hirahara N, Tajima Y, Fujii Y, Kaji S, Yamamoto T, Hyakudomi R, Taniura T, Miyazaki Y, Kishi T, Kawabata Y, et al. Preoperative prognostic nutritional index predicts long-term surgical outcomes in patients with esophageal squamous cell carcinoma. World J Surg. 2018;42(7):2199–208. doi:10.1007/s00268-017-4437-1
   PubMed Web of Science ®Google Scholar
• Hong S, Zhou T, Fang W, Xue C, Hu Z, Qin T, Tang Y, Chen Y, Ma Y, Yang Y, et al. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumor Biol. 2015;36(5):3389–3397. doi:10.1007/s13277-014-2973-y
   PubMedGoogle Scholar
• Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Sho M. Prognostic significance of the Prognostic Nutritional Index in patients with recurrent esophageal squamous cell carcinoma. Nutr Cancer. 2018;70(3):467–473. doi:10.1080/01635581.2018.1445771
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao P, Song Y, Sun J, Chen X, Zhao J, Ma B, Wang Z. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol. 2016;42(8):1176–1182. doi:10.1016/j.ejso.2016.05.029
   PubMed Web of Science ®Google Scholar
• Andersen KK, Olsen TS. The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke. 2015;10(1):99–104. doi:10.1111/ijs.12016
   PubMed Web of Science ®Google Scholar
• Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61. doi:10.1001/archinte.165.1.55
   PubMedGoogle Scholar
• Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, Manson JE, Hu FB. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233–244. doi:10.1056/NEJMoa1304501
   PubMed Web of Science ®Google Scholar
• Weir CB, Jan A. BMI Classification percentile and cut off points. Treasure Island (FL): StatPearls; 2019.
   Google Scholar
• Martínez-Galindo MG, Zamarripa-Dorsey F, Carmona-Castañeda A, Angeles-Labra A, Peñavera-Hernández R, Ugarte-Briones C, Blanco-Vela CI. Histopathologic characteristics of gastric adenocarcinoma in Mexican patients: a 10-year experience at the Hospital Juárez of Mexico. Rev Gastroenterol Mex. 2015;80(1):21–26. doi:10.1016/j.rgmxen.2015.03.003
   PubMed Web of Science ®Google Scholar
• Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128(7):765–770.
   PubMed Web of Science ®Google Scholar
• Liu BZ, Tao L, Chen YZ, Li XZ, Dong YL, Ma YJ, Li SG, Li F, Zhang WJ. Preoperative Body Mass Index, blood albumin and triglycerides predict survival for patients with gastric cancer. PLoS One. 2016;11(6):e0157401. doi:10.1371/journal.pone.0157401
   PubMed Web of Science ®Google Scholar
• Sun L, Zhu Y, Qian Q, Tang L. Body mass index and prognosis of breast cancer: an analysis by menstruation status when breast cancer diagnosis. Medicine (Baltimore. ). 2018;97(26):e11220. doi:10.1097/MD.0000000000011220
   PubMed Web of Science ®Google Scholar
• Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, Mikklineni N, Fiegoli B, Kim PH, Voss MH, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105(24):1862–1870. doi:10.1093/jnci/djt310
   PubMedGoogle Scholar
• Cao J, Ge MH, Ling ZQ. Fbxw7 tumor suppressor: a vital regulator contributes to human tumorigenesis. Medicine (Baltimore). 2016;95(7):e2496doi:10.1097/MD.0000000000002496
   PubMed Web of Science ®Google Scholar
• Li M-R, Zhu C-C, Ling T-L, Zhang Y-Q, Xu J, Zhao E-H, Zhao G. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma. BMC Gastroenterol. 2017;17(1):60. doi:10.1186/s12876-017-0616-7
   PubMed Web of Science ®Google Scholar
• Deng W, Wang J, Zhang J, Cai J, Bai Z, Zhang Z. TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells. IUBMB Life. 2016;68(5):355–64. doi:10.1002/iub.1490
   PubMed Web of Science ®Google Scholar
• Miettinen M, Lasota J. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review. Int J Biochem Cell Biol. 2014;53:514–9. doi:10.1016/j.biocel.2014.05.033
   PubMed Web of Science ®Google Scholar
• Broughman JR, Williams GR, Deal AM, Yu H, Nyrop KA, Alston SM, Gordon B-B, Sanoff HK, Muss HB. Prevalence of sarcopenia in older patients with colorectal cancer. J Geriatr Oncol. 2015;6(6):442–445. doi:10.1016/j.jgo.2015.08.005
   PubMed Web of Science ®Google Scholar
• Gioulbasanis I, Baracos VE, Giannousi Z, Xyrafas A, Martin L, Georgoulias V, Mavroudis D. Baseline nutritional evaluation in metastatic lung cancer patients: mini nutritional assessment versus weight loss history. Ann Oncol. 2011;22(4):835–841. doi:10.1093/annonc/mdq440
   PubMed Web of Science ®Google Scholar
• Kritchevsky SB, Wilcosky TC, Morris DL, Truong KN, Tyroler HA. Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res. 1991;51(12):3198–3203.
   PubMed Web of Science ®Google Scholar
• Bordonaro M, Lazarova D. Hypothesis: obesity is associated with a lower mutation threshold in colon cancer. J Cancer. 2015;6(9):825–831. doi:10.7150/jca.12352
   PubMed Web of Science ®Google Scholar